Glucose dysregulation and hepatic steatosis in obese adolescents: is there a link?
about
The Effectiveness of Different Diet Strategies to Reduce Type 2 Diabetes Risk in YouthBiomarker-Based Approaches for Assessing Alcohol Use DisordersWax esters from the marine copepod Calanus finmarchicus reduce diet-induced obesity and obesity-related metabolic disorders in micePancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver diseaseNonalcoholic fatty liver disease in adolescents and young adults: The next frontier in the epidemic.Newly diagnosed diabetes mellitus as a risk factor for serious liver diseaseUnderstanding the pathophysiological mechanisms in the pediatric non-alcoholic fatty liver disease: The role of genetics.Pathologic Impact of Insulin Resistance and Sensitivity on the Severity of Liver Histopathology in Pediatric Non-Alcoholic Steatohepatitis.The Role of Lipid and Lipoprotein Metabolism in Non-Alcoholic Fatty Liver Disease.Nonalcoholic fatty liver disease and the heart in children and adolescents.Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescentsCellularity and adipogenic profile of the abdominal subcutaneous adipose tissue from obese adolescents: association with insulin resistance and hepatic steatosis.Toward a unifying hypothesis of metabolic syndrome.Hepatic fat accumulation is modulated by the interaction between the rs738409 variant in the PNPLA3 gene and the dietary omega6/omega3 PUFA intakeLiver fat content, evaluated through semi-quantitative ultrasound measurement, is associated with impaired glucose profiles: a community-based study in ChineseNormal range of hepatic fat fraction on dual- and triple-echo fat quantification MR in children.T1-weighted dual-echo MRI for fat quantification in pediatric nonalcoholic fatty liver disease.Metabolic inflexibility and insulin resistance in obese adolescents with non-alcoholic fatty liver diseaseWorld Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease: part 3.SirT1 regulates adipose tissue inflammation.A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescentsHepatic De Novo Lipogenesis in Obese Youth Is Modulated by a Common Variant in the GCKR GeneOxidized metabolites of linoleic acid as biomarkers of liver injury in nonalcoholic steatohepatitis.Role of TM6SF2 rs58542926 in the pathogenesis of nonalcoholic pediatric fatty liver disease: A multiethnic studyA Role of the Inflammasome in the Low Storage Capacity of the Abdominal Subcutaneous Adipose Tissue in Obese Adolescents.Decreased transcription of ChREBP-α/β isoforms in abdominal subcutaneous adipose tissue of obese adolescents with prediabetes or early type 2 diabetes: associations with insulin resistance and hyperglycemiaComparative accuracy of CT, dual-echo MRI and MR spectroscopy for preoperative liver fat quantification in living related liver donors.The association between hepatic fat content and liver injury in obese children and adolescents: effects of ethnicity, insulin resistance, and common gene variantsType 2 diabetes in youth: epidemiology and pathophysiology.Childhood metabolic syndrome: must we define it to deal with it?Non-alcoholic fatty liver disease and outcomes in persons with acute coronary syndromes: insights from the GRACE-ALT analysisCirculating levels of FGF-21 in obese youth: associations with liver fat content and markers of liver damageComparison of magnetic resonance spectroscopy, proton density fat fraction and histological analysis in the quantification of liver steatosis in children and adolescents.Downregulation of ADIPOQ and PPARγ2 gene expression in subcutaneous adipose tissue of obese adolescents with hepatic steatosis.1H-MRS measured ectopic fat in liver and muscle is associated with the metabolic syndrome in Danish girls but not in boys with overweight and obesity.Biomarkers of alcohol consumption and related liver disease.Metabolic syndrome in childhood from impaired carbohydrate metabolism to nonalcoholic fatty liver disease.Islet function in obese adolescents.Progression of β-cell dysfunction in obese youth.Metabolic syndrome in youth: current insights and novel serum biomarkers.
P2860
Q26741604-3B7093A4-B272-49FA-9337-03A85A3B26ECQ26772931-D82327F7-488F-48E6-BD17-DC21E0B214EEQ28302954-DA44E160-E10F-4D7A-8C71-F0E1DF48FDBAQ28649518-78BEED11-3CDC-428C-966B-4F1D4F1B147FQ30238933-B0311A9F-A918-463D-92AB-FCDC6E9130B0Q30495922-F261D47B-E711-40CA-A795-0C5DFDD894EFQ33360950-2307E78F-822A-48AC-ACB9-58442AD97E78Q33734988-357A5A81-709B-4A26-B225-758CCC2AA5A0Q33831711-F4682A97-59D8-49AC-9DFA-6D3E1F102F73Q33958722-DCF4FB6E-C785-4411-9C54-46FD7B11497BQ34016080-AED0053E-947C-4A41-9C06-135B7C218F8CQ34082884-E729DC86-2D19-4A09-BEF3-F333BB0CE741Q34255878-AD8C90F9-B8CF-455B-AA57-EFC7AB42F2F8Q34282151-371F8DAE-CAA3-457A-8FC7-5581DB997F8CQ34811955-9914688B-9739-4040-AC9E-DA1C7174EBDEQ35057832-1444CBA9-930C-432F-AE47-941D6AC2152FQ35093622-FBFA669C-35BF-4605-9AC6-23FFCE0AB7D1Q35118774-A4137D68-EDD5-4F77-A975-DE1228D578B5Q35179847-0CC9F6A6-26B0-4862-8457-BFA815E0D0C1Q35561122-94150AFE-D31B-4AC3-8EB8-3F55336DE1BAQ35564927-4AF5889A-9A4E-4FE8-A363-7BD0D63EC967Q35916492-94D45023-1694-4521-9BAF-A9DC29836884Q36083096-9A8AEB66-F60C-4B3B-B47F-6C789F068FDCQ36396108-4394240A-EE5B-4408-BB47-D62CDFA10A7EQ36608773-10BEC683-DE51-4666-9497-9BED246EB385Q36635387-71895741-9AE8-4837-8136-0113089890A6Q36743255-3D70551C-895D-4BA2-86B7-06B66091AC30Q36782785-D7FC9B8D-95D0-4368-81A7-8F089B0AAAE5Q36783734-B392CA58-4B10-401D-9C2A-3C2287F0CC2DQ36783744-5C3210B2-4286-49B9-997C-FBE240C9C7BDQ36800784-718FC617-E7AF-422E-8A4B-33F55134A01CQ36982020-D675EAC4-4A5A-4AA7-98F2-750F2AB97B2BQ37359632-53E24B65-3DCB-4A12-A26D-101727DB6FAEQ37503883-5638A40E-F743-49C0-B81B-C5F110B3F83EQ37539622-D5AC7DDB-4488-4A7A-AB9F-7E6892DBFD24Q37752443-B99E2371-BC64-4928-8376-19603287752FQ37955877-05A7DC9D-23AC-4F5E-813E-38CC6EFF4CE8Q38038650-19499F58-DD5A-4B24-AF36-FDB75A318D5EQ38062439-2C17A753-8742-4A6B-A050-7E021B96C768Q38066238-B1CBCFB8-6344-47F3-A5CB-AE45D2E06974
P2860
Glucose dysregulation and hepatic steatosis in obese adolescents: is there a link?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Glucose dysregulation and hepatic steatosis in obese adolescents: is there a link?
@en
Glucose dysregulation and hepatic steatosis in obese adolescents: is there a link?
@nl
type
label
Glucose dysregulation and hepatic steatosis in obese adolescents: is there a link?
@en
Glucose dysregulation and hepatic steatosis in obese adolescents: is there a link?
@nl
prefLabel
Glucose dysregulation and hepatic steatosis in obese adolescents: is there a link?
@en
Glucose dysregulation and hepatic steatosis in obese adolescents: is there a link?
@nl
P2093
P2860
P921
P356
P1433
P1476
Glucose dysregulation and hepatic steatosis in obese adolescents: is there a link?
@en
P2093
Ana Mayra De Oliveira
Anna M G Cali
Bridget Pierpont
Hyeonjin Kim
James Dziura
Mary Savoye
Melissa Shaw
Miguel Reyes-Mugica
R Todd Constable
Romy Kursawe
P2860
P304
P356
10.1002/HEP.22858
P407
P50
P577
2009-06-01T00:00:00Z